Latest News Releases

PTA-Adhoc: Biofrontera AG: Appointment of Mrs Pilar de la Huerta Martinez as new Chief Financial Officer

Public disclosure of inside information according to article 17 MAR

Leverkusen, Germany (pta023/19.08.2022/21:15) - Biofrontera AG announces that the Supervisory Board of Biofrontera AG, by resolution of today, has appointed Mrs Pilar de la Huerta as new Chief Financial Officer of Biofrontera AG with effect as of 12 September 2022. Mrs Pilar de la Huerta has 25 years of experience in the healthcare sector and has held various positions with responsibility as CFO und CEO in technology driven organizations in Pharma and Healthcare.


emitter: Biofrontera AG
address: Hemmelrather Weg 201, 51377 Leverkusen
country: Germany
contact person: Investor Relations
phone: +49 (0) 214 87 63 20

ISIN(s): DE0006046113 (share)
stock exchanges: regulated market in Frankfurt, Dusseldorf; free market in Stuttgart, free market in Munich; open market in Berlin, Tradegate
other stock exchanges: US OTC

[ source: ]

Biofrontera AG – an attractive investment

We are experts in photodynamic therapy. With our innovative products and treatment methods, we make our contribution to skin health and at the same time create value for our investors.

Biofrontera is listed on the Frankfurt Stock Exchange (B8F).